Cargando…
Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment
Wilson’s disease (WD) is an inherited metabolic disorder related to disturbances of copper metabolism, and predominantly presents with liver and neuropsychiatric symptoms. In most cases it can be successfully treated with anti-copper agents, and both liver function and neuropsychiatric symptoms typi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022881/ https://www.ncbi.nlm.nih.gov/pubmed/29977520 http://dx.doi.org/10.1177/2045125318759461 |
_version_ | 1783335754689150976 |
---|---|
author | Litwin, Tomasz Dusek, Petr Szafrański, Tomasz Dzieżyc, Karolina Członkowska, Anna Rybakowski, Janusz K. |
author_facet | Litwin, Tomasz Dusek, Petr Szafrański, Tomasz Dzieżyc, Karolina Członkowska, Anna Rybakowski, Janusz K. |
author_sort | Litwin, Tomasz |
collection | PubMed |
description | Wilson’s disease (WD) is an inherited metabolic disorder related to disturbances of copper metabolism, and predominantly presents with liver and neuropsychiatric symptoms. In most cases it can be successfully treated with anti-copper agents, and both liver function and neuropsychiatric symptoms typically improve. Treatment guidelines for WD include recommendations for anti-copper treatment as well as for the treatment of liver failure symptoms. Recently, recommendations for treatment of the neurological symptoms of WD have also been proposed. Although most WD patients present with psychiatric symptoms at some stage of the disease, currently there are no guidelines for the treatment of the psychiatric manifestations. Treatment of the psychiatric symptoms of WD is often guided by general psychiatric experience, which typically glosses over the specificity of WD, and can result in severe neurological and/or hepatic complications. Here we review and discuss the possible treatments available for the mood disturbances, psychosis, behavioral and cognitive disorders that can occur in WD, as well as their efficacy. |
format | Online Article Text |
id | pubmed-6022881 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-60228812018-07-06 Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment Litwin, Tomasz Dusek, Petr Szafrański, Tomasz Dzieżyc, Karolina Członkowska, Anna Rybakowski, Janusz K. Ther Adv Psychopharmacol Review Article Wilson’s disease (WD) is an inherited metabolic disorder related to disturbances of copper metabolism, and predominantly presents with liver and neuropsychiatric symptoms. In most cases it can be successfully treated with anti-copper agents, and both liver function and neuropsychiatric symptoms typically improve. Treatment guidelines for WD include recommendations for anti-copper treatment as well as for the treatment of liver failure symptoms. Recently, recommendations for treatment of the neurological symptoms of WD have also been proposed. Although most WD patients present with psychiatric symptoms at some stage of the disease, currently there are no guidelines for the treatment of the psychiatric manifestations. Treatment of the psychiatric symptoms of WD is often guided by general psychiatric experience, which typically glosses over the specificity of WD, and can result in severe neurological and/or hepatic complications. Here we review and discuss the possible treatments available for the mood disturbances, psychosis, behavioral and cognitive disorders that can occur in WD, as well as their efficacy. SAGE Publications 2018-03-06 2018-07 /pmc/articles/PMC6022881/ /pubmed/29977520 http://dx.doi.org/10.1177/2045125318759461 Text en © The Author(s), 2018 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Review Article Litwin, Tomasz Dusek, Petr Szafrański, Tomasz Dzieżyc, Karolina Członkowska, Anna Rybakowski, Janusz K. Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment |
title | Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment |
title_full | Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment |
title_fullStr | Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment |
title_full_unstemmed | Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment |
title_short | Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment |
title_sort | psychiatric manifestations in wilson’s disease: possibilities and difficulties for treatment |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022881/ https://www.ncbi.nlm.nih.gov/pubmed/29977520 http://dx.doi.org/10.1177/2045125318759461 |
work_keys_str_mv | AT litwintomasz psychiatricmanifestationsinwilsonsdiseasepossibilitiesanddifficultiesfortreatment AT dusekpetr psychiatricmanifestationsinwilsonsdiseasepossibilitiesanddifficultiesfortreatment AT szafranskitomasz psychiatricmanifestationsinwilsonsdiseasepossibilitiesanddifficultiesfortreatment AT dziezyckarolina psychiatricmanifestationsinwilsonsdiseasepossibilitiesanddifficultiesfortreatment AT członkowskaanna psychiatricmanifestationsinwilsonsdiseasepossibilitiesanddifficultiesfortreatment AT rybakowskijanuszk psychiatricmanifestationsinwilsonsdiseasepossibilitiesanddifficultiesfortreatment |